how do bcl2 inhibitors work?
Published 2 months ago • 223 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:37
identifying human cancers to target with bcl-2 inhibition
-
1:06
safety analysis of the bcl-2 inhibitor venetoclax for cll
-
1:27
advances in btk and bcl2 inhibitors for cll
-
3:33
venetoclax (bcl 2 inhibitor)
-
2:22
cll whiteboard #3: mechanisms of action of anti-apoptotic bcl2 inhibitors
-
1:17
dr. davids on the phase ii crc043 trial for patients with richter's syndrome
-
13:36
aml on the go - bcl-2 inhibition in acute myeloid leukemia
-
35:43
multiple myeloma: bone health | dana-farber cancer institute
-
3:23
venetoclax plus chemotherapy for older patients with acute lymphoblastic leukemia (all)
-
59:52
behind the breakthroughs: new hope, new options for lymphoid and myeloid cancers
-
2:32
our momentum of discovery | dana-farber cancer institute
-
1:51
kidney cancer research: hif-2α inhibition
-
47:06
future directions for novel and next generation therapy in multiple myeloma | dana-farber
-
47:51
benjamin ebert - dana-farber targeted degradation webinar series
-
21:58
dongwen lyu (lv) - dana-farber targeted degradation webinar series
-
8:32
lisaftoclax for chronic lymphocytic leukemia treatment - dr. matthew davids ash 2022
-
2:05
expanded treatment options for acute myeloid leukemia (aml)
-
58:41
update on diagnosis and therapy of plasma cell dyscrasias